|
|
||||||||
RAPID COMMUNICATION |
a Stem Cell Biology Program at James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA;
b Department of Transplantology, Polish-American Childrens Hospital at Jagiellonian University, Cracow, Poland
Key Words. Stem cell plasticity • CXCR4 • SDF-1 • Muscle satellite cells • Hematopoietic stem/progenitor cells
Correspondence:
Mariusz Z. Ratajczak M.D., Ph.D., Stem Cell Biology Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA. Telephone: 502-852-1788; Fax: 502-852-3032; e-mail: mzrata01{at}louisville.edu
| ABSTRACT |
|---|
|
|
|---|
-chemokine stromal-derived factor 1 (SDF-1), is secreted in muscle tissue. These cell lines responded to SDF-1 stimulation by chemotaxis, phosphorylation of mitogen-activated protein kinase (MAPK) p42/44 and AKT serine-threonine kinase, and calcium flux, confirming the functionality of the CXCR4 receptor. Moreover, supernatants derived from muscle fibroblasts chemoattracted both satellite cells and human CD34+ hematopoietic stem/progenitor cells. In a similar set of experiments, supernatants from bone marrow fibroblasts were found to chemoattract CXCR4+ satellite cells just as they chemoattract CD34+ cells. Moreover, preincubation of both muscle satellite cells and hematopoietic stem/progenitor CD34+ cells before chemotaxis with T140, a specific CXCR4 inhibitor, resulted in a significantly lower chemotaxis to media conditioned by either muscle- or bone marrow-derived fibroblasts. Based on these observations, we postulate that the SDF-1-CXCR4 axis is involved in chemoattracting circulating CXCR4+ muscle stem/progenitor and circulating CXCR4+ hematopoietic CD34+ cells to both muscle and bone marrow tissues. Thus, it appears that tissue-specific stem cells circulating in peripheral blood could compete for SDF-1+ niches, and this would explain, without invoking the concept of stem cell plasticity, why hematopoietic colonies can be cultured from muscles and early muscle progenitors can be cultured from bone marrow.
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Expression and Functional Analysis of CXCR4
Murine satellite C2C12 and G7 cells were obtained from American Type Culture Collection (ATCC; Rockville, MD; http://www.atcc.org). These cells were cultured in DMEM supplemented with 100 IU/ml penicillin, 10 µg/ml streptomycin, and 50 µg/ml neomycin in the presence of 10% FBS and, in order to induce myotube formation and differentiation, cells were exposed to high-glucose media according to the ATCC protocol. Expression of CXCR4 in these cells lines was evaluated by RT-PCR. Primer sequences for murine CXCR4 were forward primer: 5'-CCC GAT AGC CTG TGG ATG GTG GTG T-3' and reverse primer: 5'-AGC TTT TGA ACT TGG CCC CGA GGA A-3'. The responses of these cells to SDF-1 were evaluated using phosphorylation of intracellular pathway proteins, calcium flux, and chemotaxis assays. Briefly, cells were kept in RPMI medium containing low levels of bovine serum albumin (BSA) (0.5%) to render the cells quiescent and then stimulated with SDF-1ß (100300 ng/ml) or hepatocyte growth factor (HGF, 10 ng/ml) for 210 minutes. The extracted proteins were separated on a 12% SDS-PAGE gel and transferred onto a nitrocellulose membrane (Schleicher & Schuell; Keene, NH; http://www.schleicher-schuell.com), as previously described [1113]. Phosphorylation of the intracellular kinases mitogen-activated protein kinase (MAPK) p44/42 (Thr 202/Tyr 204) and AKT was detected using commercial mouse phospho-specific monoclonal antibody (mAb) for MAPK p44/42 and rabbit phospho-specific polyclonal antibodies for AKT (all from Cell Signaling, New England Biolabs; Beverly, MA; http://www.net.com), with horseradish peroxidase-conjugated goat anti-mouse IgG or goat anti-rabbit IgG as secondary antibodies (Cell Signaling, New England Biolabs). Equal loading in the lanes was evaluated by stripping the blots and reprobing with appropriate mAbs: p42/44 anti-MAPK antibody clone #9102 and anti-AKT antibody clone #9272 (Santa Cruz Biotechnology; Santa Cruz, CA; htttp://www.scbt.com). The membranes were developed with an ECL reagent (Amersham Biosciences; Little Chalfont, UK), dried, and subsequently exposed to film (HyperFilm; Amersham). For calcium flux studies, cells were incubated for 30 minutes at 30°C with 12 µM Fura-2/AM (Molecular Probes; Eugene, OR; http://www.probes.com). After incubation, cells were washed once, resuspended in loading buffer, and analyzed within 1 hour. For directional chemotaxis studies, murine satellite C2C12, G7, or hematopoietic Sca-1+ cells or human bone marrow-derived CD34+ cells were made quiescent, as described above, and the directional movement of cells toward the gradient of SDF-1 concentration across an 8-µm (satellite cells) or 5-µm (Sca-1+ and CD34+ cells) pore polycarbonate membrane was evaluated, as described previously [1113]. The lower chamber was filled either with SDF-1 at a concentration of 100 ng/ml or with conditioned media derived from human or murine bone marrow- or muscle-tissue-derived fibroblasts. A 0.5% BSA RPMI medium was used as a negative control. The inserts were removed from the transwells after 48 hours (for satellite cells) or 3 hours (for Sca-1+ and CD34+ cells), and the cells remaining in the upper chambers were scraped off with cotton wool. The cells that had transmigrated were counted, either on the lower side of the membrane (satellite cells) or on the bottom of the transwells (hematopoietic cells), as described previously [12]. Some of the directional migration experiments were performed using cells preincubated (for 30 minutes at 37°C) in the presence of 1 µM T140-truncated polyphemusin [14] analogue (a gift of Dr. Nobutaka Fuji, Kyoto University, Japan) or with anti-CXCR4 (10 µg/ml). In the chemotaxis experiments, supernatants conditioned by bone marrow stroma cells were pretreated with anti-SDF-1 (100 µg/ml) (R&D Systems, Inc.; Minneapolis, MN; http://www.rndsystems.com), as previously described [12].
Detection of mRNA for Early Muscle Markers in Peripheral Blood Mononuclear Cells
Mononuclear cells were isolated from peripheral blood obtained from three normal participants and three patients, mobilized by G-CSF. RT-PCR for early muscle markers was performed using the following primers: for MyoD, the forward primer was 5'-CGG CGG CGG AAC TGC TAC GAA-3' and the reverse primer was 5'-GGG GCG GGG GCG GAA ACT T-3'; and for myogenin, the forward primer was 5'-AGC GCC CCC TCG TGT ATG-3' and the reverse primer was 5'-TGT CCC CGG CAA CTT CAG C-3'. Primer sequences were evaluated for their specificity at the National Center for Biotechnology Information, Bethesda, MD.
| STATISTICAL ANALYSES |
|---|
|
|
|---|
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
We reported recently that human rhabdomyosarcoma cells highly expressed the receptor CXCR4 on their surface [12]. Since rhabdomyosarcomas may originate from very primitive muscle cells, we asked whether CXCR4 was expressed by muscle stem/progenitor cells as well. To address this question, we selected two murine satellite cell lines, G7 and C2C12, and, by employing RT-PCR and Western blotting, we found that CXCR4 was expressed on those cells (Fig. 1
). Next, to determine whether CXCR4 was functional on those cells, we stimulated them with SDF-1 (Fig. 2
) and found that they responded to SDF-1 stimulation with chemotaxis, phosphorylation of MAPK p42/44 and AKT, and calcium flux. Since the c-met receptor is a marker of muscle satellite cells [18], we employed its specific ligand, HGF, as a positive control.
|
|
Thus, our data provide new evidence that the CXCR4-SDF-1 axis could be involved in muscle development by regulating the biology of muscle progenitor/satellite cells. Supporting this is a report that mouse embryos with CXCR4 and SDF-1 knockouts displayed defects in heart muscle formation [19, 20]. We suggest additional studies be done to see whether other muscle-related defects are present in these animals.
Next, because SDF-1 is secreted by bone marrow-derived fibroblasts [17, 18], we further hypothesized that circulating hematopoietic stem/progenitor cells both in humans and mice could be chemoattracted to muscle tissue in a CXCR4-SDF-1-dependent manner. As human and murine SDF-1 show species cross-reactivity, we studied the chemoattraction of human CD34+ bone marrow-derived cells to conditioned media harvested from ex vivo-expanded human muscle-derived fibroblasts (Fig. 3
). We found that conditioned media harvested from human heart- and skeletal muscle-derived fibroblasts chemoattracted CD34+ cells (Figs. 3A
and 3B
, respectively). Recombinant SDF-1 or conditioned media harvested from bone marrow fibroblasts were employed as positive controls (Fig. 3A
). Moreover, when those cells were preincubated with T140 [14] before chemotaxis, or the conditioned media were precleared with anti-SDF-1 antibodies, less chemoattraction was observed (Fig. 3
). However, since there was still some chemotaxis observed, other chemoattractants not yet identified could be involved. On the basis of these experiments, we postulate that the chemoattraction of CD34+ cells by muscle tissue-derived fibroblasts provides a molecular explanation for why circulating hematopoietic stem/progenitor cells can be detected in muscle tissue [46, 9, 15]. Moreover, since muscle-derived fibroblasts in addition to SDF-1 (Fig. 4
) may secrete other hematopoietic factors, such as, for example, KL (Fig. 4B
), these cells find a supportive environment that protects them from undergoing apoptosis.
|
|
|
It has long been recognized that peripheral blood is a "highway" for lymphoid memory cells and hematolymphopoietic stem cells circulating in the body [21]. Recent data have also demonstrated the presence in the peripheral blood of other stem cells that are able to give rise to cells of neural or muscle tissues [9, 22]. Based on these observations, we hypothesized that, in addition to hematolymphopoietic stem cells, other tissue-specific stem cells may also use this route to maintain a balanced pool of tissue-specific stem cells. This would be especially important for the stem cells of tissues that are located in anatomic locations dispersed throughout the body. Thus, hematopoietic and muscle stem cells need to circulate to maintain a balanced pool of stem cells between distant areas of bone marrow and muscles; likewise, neuroectodermal stem cells may also circulate to maintain a stem cell pool in the adrenal medulla and the sympathetic nervous system. Supporting this latter idea is the fact that SDF-1 is also secreted by neural tissue, and CXCR4 is expressed on the surface of early neural cells [23, 24]. Hence, a similar mechanism to the one described here for muscle satellite cells may explain why neural progenitors are detectable in hematopoietic tissues [22] and why HSCs are found in the brain [25]. Since we recently found that CXCR4 is expressed by murine embryonic stem cells (unpublished), it seems likely that the SDF-1-CXCR4 axis could play a more universal role in regulating trafficking of tissue-specific stem cells [26]. In support of this, CXCR4 was recently described as playing an important role in the migration of primordial germ cells [27]. Our preliminary data (Fig. 6
) suggest that circulating early muscle tissue-specific precursor cells that express MyoD are present in peripheral blood during mobilization.
|
|
| ACKNOWLEDGMENT |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. C. Young, E. Torres, K. E. Hatzistergos, D. Hehre, C. Suguihara, and J. M. Hare Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension Circ. Res., June 5, 2009; 104(11): 1293 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Paczkowska, M. Kucia, D. Koziarska, M. Halasa, K. Safranow, M. Masiuk, A. Karbicka, M. Nowik, P. Nowacki, M. Z. Ratajczak, et al. Clinical Evidence That Very Small Embryonic-Like Stem Cells Are Mobilized Into Peripheral Blood in Patients After Stroke Stroke, April 1, 2009; 40(4): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lee, J. E. Dennis, and S. L. Gerson Imaging Stem Cell Implant for Cellular-Based Therapies Experimental Biology and Medicine, August 1, 2008; 233(8): 930 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, Y. Shiozawa, J. Wang, Y. Wang, Y. Jung, K. J. Pienta, R. Mehra, R. Loberg, and R. S. Taichman The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer J. Biol. Chem., February 15, 2008; 283(7): 4283 - 4294. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stellos, H. Langer, K. Daub, T. Schoenberger, A. Gauss, T. Geisler, B. Bigalke, I. Mueller, M. Schumm, I. Schaefer, et al. Platelet-Derived Stromal Cell-Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+ Cells to Endothelial Progenitor Cells Circulation, January 15, 2008; 117(2): 206 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda Circulating Bone Marrow-Derived Osteoblast Progenitor Cells Are Recruited to the Bone-Forming Site by the CXCR4/Stromal Cell-Derived Factor-1 Pathway Stem Cells, January 1, 2008; 26(1): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Odemis, K. Boosmann, M. T. Dieterlen, and J. Engele The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta} J. Cell Sci., November 15, 2007; 120(22): 4050 - 4059. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, N. Mal, M. Kiedrowski, M. Chacko, A. T. Askari, Z. B. Popovic, O. N. Koc, and M. S. Penn SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction FASEB J, October 1, 2007; 21(12): 3197 - 3207. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhu, O. Boachie-Adjei, B. A. Rawlins, B. Frenkel, A. L. Boskey, L. B. Ivashkiv, and C. P. Blobel A Novel Regulatory Role for Stromal-derived Factor-1 Signaling in Bone Morphogenic Protein-2 Osteogenic Differentiation of Mesenchymal C2C12 Cells J. Biol. Chem., June 29, 2007; 282(26): 18676 - 18685. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schenk, N. Mal, A. Finan, M. Zhang, M. Kiedrowski, Z. Popovic, P. M. McCarthy, and M. S. Penn Monocyte Chemotactic Protein-3 Is a Myocardial Mesenchymal Stem Cell Homing Factor Stem Cells, January 1, 2007; 25(1): 245 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lemoli, L. Catani, S. Talarico, E. Loggi, A. Gramenzi, U. Baccarani, M. Fogli, G. L. Grazi, M. Aluigi, G. Marzocchi, et al. Mobilization of Bone Marrow-Derived Hematopoietic and Endothelial Stem Cells After Orthotopic Liver Transplantation and Liver Resection Stem Cells, December 1, 2006; 24(12): 2817 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mieno, B. Ramlawi, M. Boodhwani, R. T. Clements, K. Minamimura, T. Maki, S.-H. Xu, C. Bianchi, J. Li, and F. W. Sellke Role of Stromal-Derived Factor-1{alpha} in the Induction of Circulating CD34+CXCR4+ Progenitor Cells After Cardiac Surgery. Circulation, July 4, 2006; 114(1 Suppl): 186 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, R. G. Reca, P. Atmaca-Sonmez, M. Z. Ratajczak, S. T. Ildstad, H. J. Kaplan, and V. Enzmann Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow-derived stem cells. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1646 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wojakowski, M. Tendera, A. Zebzda, A. Michalowska, M. Majka, M. Kucia, K. Maslankiewicz, R. Wyderka, M. Krol, A. Ochala, et al. Mobilization of CD34+, CD117+, CXCR4+, c-met+ stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction Eur. Heart J., February 1, 2006; 27(3): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Memon, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Taketani, S. K. Sakakida, H. Kondoh, A. N. Aleshin, T. Shimizu, et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1333 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Yamani, N. B. Ratliff, D. J. Cook, E. M. Tuzcu, Y. Yu, R. Hobbs, G. Rincon, C. Bott-Silverman, J. B. Young, N. Smedira, et al. Peritransplant Ischemic Injury Is Associated With Up-Regulation of Stromal Cell-Derived Factor-1 J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vasyutina, J. Stebler, B. Brand-Saberi, S. Schulz, E. Raz, and C. Birchmeier CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells Genes & Dev., September 15, 2005; 19(18): 2187 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Memon, Y. Sawa, S. Miyagawa, S. Taketani, and H. Matsuda Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 646 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kucia, R. Reca, K. Miekus, J. Wanzeck, W. Wojakowski, A. Janowska-Wieczorek, J. Ratajczak, and M. Z. Ratajczak Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis Stem Cells, August 1, 2005; 23(7): 879 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kucia, B. Dawn, G. Hunt, Y. Guo, M. Wysoczynski, M. Majka, J. Ratajczak, F. Rezzoug, S. T. Ildstad, R. Bolli, et al. Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction Circ. Res., December 10, 2004; 95(12): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. De Falco, D. Porcelli, A. R. Torella, S. Straino, M. G. Iachininoto, A. Orlandi, S. Truffa, P. Biglioli, M. Napolitano, M. C. Capogrossi, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells Blood, December 1, 2004; 104(12): 3472 - 3482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Reca, K. Jankowski, G. Przybylski, A. Janowska-Wieczorek, and M. Z. Ratajczak CXCR4 Is a PAX Family Transcription Factor Regulated Gene. Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 4205 - 4205. [Abstract] |
||||
![]() |
W. Wojakowski, M. Tendera, A. Michalowska, M. Majka, M. Kucia, K. Maslankiewicz, R. Wyderka, A. Ochala, and M. Z. Ratajczak Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction Circulation, November 16, 2004; 110(20): 3213 - 3220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ratajczak, R. Reca, M. Kucia, M. Majka, D. J. Allendorf, J. T. Baran, A. Janowska-Wieczorek, R. A. Wetsel, G. D. Ross, and M. Z. Ratajczak Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow Blood, March 15, 2004; 103(6): 2071 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Dreyfus, F. Chretien, B. Chazaud, Y. Kirova, P. Caramelle, L. Garcia, G. Butler-Browne, and R. K. Gherardi Adult Bone Marrow-Derived Stem Cells in Muscle Connective Tissue and Satellite Cell Niches Am. J. Pathol., March 1, 2004; 164(3): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |